Media Mentions

The Arizona Diamondbacks hosted an incredible game dedicated to brain tumor awareness! The Ivy Center is incredibly thankful for the generosity of the Nicole Hazen Fund for Hope, which donated $200,000 to support our research efforts. The impact of this donation was further amplified by The Women’s Board of Barrow Neurological Foundation and The Rick Oehme Foundation, who matched the contribution, resulting in a total contribution of $400,000. Additionally, the D-backs Give Back 50/50 Raffle raised over $40,000 from the fantastic support of attendees.

As a neurosurgical resident at Barrow Neurological Institute, Charuta Furey is paving the way for women in her field. At the age of seven, Charuta’s mother was diagnosed with a glioma. Since that moment, Dr. Furey has committed her life to helping others who have been diagnosed with brain cancer. Check out ABC15's latest story in honor of Mother's Day.

Phoenix Magazine featured the Ivy Brain Tumor Center's Dine and Donate event for the month of May. The event is a collaboration between the Barrow Neurological Foundation and Hensley Beverage Company to raise money for brain tumor research at the Ivy Brain Tumor Center. Local eateries that participate in the fundraiser will donate a portion of their sales throughout May, or feature a special menu item to support the cause.

Christi Endicott, a brave mother of two and brain tumor survivor was featured on AZ Family News sharing her brain tumor survival story. Christi is gearing up to take on the Boston Marathon and highlights her journey and how she persevered through the challenges of brain cancer.

Jenn Ortiz, a mother of two, is celebrating three years of survivorship this August! Her journey with brain cancer began at the Ivy Center when she was diagnosed with glioblastoma. Despite the challenges she's faced, Jenn remains optimistic, inspiring those around her with her perseverance and undeniable sense of humor. Jenn joined ABC15 Arizona to share her story.

In OncLive's latest article, they highlight the medical community's increasing interest in how high-grade meningiomas, a common type of brain tumor, might be treated with genomics. Dr. Nader Sanai, at the Ivy Brain Tumor Center, discusses the potential of Phase 0 clinical trials in better testing new treatments for this type of brain cancer.

Ivy Center Postdoctoral Fellow Costanza Lo Cascio, PhD, was featured in the latest issue of Oncology Fellows. The article highlights the importance of a pharmacokinetic and pharmacodynamic-guided approach in neuro-oncology preclinical trials to fast-track development of the most promising brain-penetrant drugs for glioblastoma treatment.

The Ivy Brain Tumor Center's Pharmacodynamics Core Leader An-Chi Tien has been awarded a one-year, $50,000 grant for work in genetic analysis of meningioma tumors by the American Brain Tumor Association. 

The Ivy Center was featured on Health Tomorrow on PBS’ Arizona Horizon to discuss the challenges facing brain tumor patients and the efforts by the Ivy Center to overcome those obstacles. More brain tumor patients are treated at the Ivy Center and Barrow Neurological Institute than in any other facility in the U.S., explained Dr. Nader Sanai, director of the Ivy Center and director of Neurosurgical Oncology at Barrow Neurological Institute.

Diffuse intrinsic pontine glioma (DIPG) is a rare and deadly pediatric brain cancer with a 2% five-year survival rate. To provide therapeutic options for patients and families, SonALAsense is partnering with clinicians at the Ivy Brain Tumor Center at Barrow Neurological Institute, Phoenix Children's Hospital, and other sites to conduct a phase 1/2 clinical trial for sonodynamic therapy (SDT). This is the first SDT trial for children.